These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 24043457

  • 1. Investigation of the hemostatic effect of a transdermal patch containing 0.55 mg ethinyl estradiol and 2.1 mg gestodene compared with a monophasic oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel: an open-label, randomized, crossover study.
    Junge W, Heger-Mahn D, Trummer D, Merz M.
    Drugs R D; 2013 Sep; 13(3):223-33. PubMed ID: 24043457
    [Abstract] [Full Text] [Related]

  • 2. Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
    Merz M, Kroll R, Lynen R, Bangerter K.
    Contraception; 2015 Feb; 91(2):113-20. PubMed ID: 25453585
    [Abstract] [Full Text] [Related]

  • 3. Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
    Klipping C, Duijkers I, Parke S, Mellinger U, Serrani M, Junge W.
    Drugs R D; 2011 Feb; 11(2):159-70. PubMed ID: 21679006
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and adhesion of a transdermal patch containing ethinyl estradiol and gestodene under conditions of heat, humidity, and exercise: A single-center, open-label, randomized, crossover study.
    Zurth C, Schuett B, Casjens M, Ludwig M, Waellnitz K.
    Clin Pharmacol Drug Dev; 2015 Jul; 4(4):245-55. PubMed ID: 27136904
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptive.
    Hofmann B, Reinecke I, Schuett B, Merz M, Zurth C.
    Int J Clin Pharmacol Ther; 2014 Dec; 52(12):1059-70. PubMed ID: 25295716
    [Abstract] [Full Text] [Related]

  • 6. Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill.
    Kaunitz AM, Portman D, Westhoff CL, Archer DF, Mishell DR, Foegh M.
    Contraception; 2015 Mar; 91(3):204-10. PubMed ID: 25582984
    [Abstract] [Full Text] [Related]

  • 7. Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled study.
    Wiegratz I, Bassol S, Weisberg E, Mellinger U, Merz M.
    Reprod Sci; 2014 Dec; 21(12):1518-25. PubMed ID: 24784719
    [Abstract] [Full Text] [Related]

  • 8. An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables.
    Endrikat J, Klipping C, Cronin M, Gerlinger C, Ruebig A, Schmidt W, Düsterberg B.
    Contraception; 2002 Mar; 65(3):215-21. PubMed ID: 11929643
    [Abstract] [Full Text] [Related]

  • 9. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
    Winkler UH, Schindler AE, Endrikat J, Düsterberg B.
    Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
    [Abstract] [Full Text] [Related]

  • 10. Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 microgram ethinyl estradiol combined with 150 microgram desogestrel or 75 microgram gestodene.
    Zichella L, Sbrignadello C, Tomassini A, Di Lieto A, Montoneri C, Zarbo G, Mancone M, Pietrobattista P, Bertoli G, Perrone G.
    Adv Contracept; 1999 Feb; 15(3):191-200. PubMed ID: 11019950
    [Abstract] [Full Text] [Related]

  • 11. Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables.
    Kluft C, Meijer P, LaGuardia KD, Fisher AC.
    Contraception; 2008 Feb; 77(2):77-83. PubMed ID: 18226669
    [Abstract] [Full Text] [Related]

  • 12. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
    Davis SR, Bitzer J, Giraldi A, Palacios S, Parke S, Serrani M, Mellinger U, Nappi RE.
    J Sex Med; 2013 Dec; 10(12):3069-79. PubMed ID: 24034466
    [Abstract] [Full Text] [Related]

  • 13. Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial.
    Kaunitz AM, Portman D, Westhoff CL, Archer DF, Mishell DR, Rubin A, Foegh M.
    Obstet Gynecol; 2014 Feb; 123(2 Pt 1):295-303. PubMed ID: 24402597
    [Abstract] [Full Text] [Related]

  • 14. Effect of two low-dose gestodene containing monophasic oral contraceptives on hemostasis in Bulgarian women.
    Uchikova E, Pehlivanov B.
    Expert Opin Pharmacother; 2008 Aug; 9(11):1839-44. PubMed ID: 18627323
    [Abstract] [Full Text] [Related]

  • 15. A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study.
    Gruber D, Skřivánek A, Serrani M, Lanius V, Merz M.
    Contraception; 2015 Feb; 91(2):105-12. PubMed ID: 25453582
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic drug-drug interaction between ethinyl estradiol and gestodene, administered as a transdermal fertility control patch, and two CYP3A4 inhibitors and a CYP3A4 substrate.
    Winkler J, Goldammer M, Ludwig M, Rohde B, Zurth C.
    Eur J Drug Metab Pharmacokinet; 2015 Dec; 40(4):389-99. PubMed ID: 24997757
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W, Baumann A, Staks T, Dibbelt L, Knuppen R, Jütting G.
    Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659
    [Abstract] [Full Text] [Related]

  • 18. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ, Bromham DR, O'Connor TP, Sahota JE.
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [Abstract] [Full Text] [Related]

  • 19. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.
    Kirkman RJ, Pedersen JH, Fioretti P, Roberts HE.
    Contraception; 1994 Jan; 49(1):33-46. PubMed ID: 8137624
    [Abstract] [Full Text] [Related]

  • 20. Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol/2.1-mg gestodene: a multicenter, open-label, uncontrolled study over three treatment cycles.
    Westhoff CL, Reinecke I, Bangerter K, Merz M.
    Contraception; 2014 Sep; 90(3):272-9. PubMed ID: 24969733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.